CVS Health is preparing to raise up to $2.5 billion through a bond sale, Bloomberg reported Dec. 2. The company has engaged Barclays, Citigroup and Goldman Sachs to arrange investor calls, sources ...

To fund buybacks of some of its current debt, CVS is expected to issue hybrid securities in the range of $2 billion to $2.5 ...

A spokesperson for the National Association of Benefits and Insurance Professionals said the organization is “deeply ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers ...

Leadership changes at large publicly traded companies from Boeing to Starbucks were a feature of the corporate landscape in a ...

Sachin H. Jain’s annual healthcare industry predictions covers a wide range of topics including private equity, the incoming ...

Analysts have set 12-month price targets for CVS Health, revealing an average target of $68.83, a high estimate of $85.00, ...

The Medicare Advantage program is expected to cost taxpayers and beneficiaries more than $500 billion this year.

Taxpayers paid for their care at the VA—and for Medicare Advantage coverage that many didn’t use. ‘I don’t think I’ve used my ...

CVS Health Corporation ("CVS Health" or the "Company," NYSE: CVS) announced today that it has commenced cash tender offers (the "Tender Offers," and each a "Tender Offer") for (1) any and all of its 4 ...

CVS Health Corp. is talking to investors about possibly selling bonds and at the same time said it’s buying back as much as ...

Aerospace industry veteran Kelly Ortberg was named Boeing's new CEO in July, succeeding Dave Calhoun to turn the struggling ...